{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Early+Parkinson+Disease+%28Early+PD%29&page=2", "query": { "condition": "Early Parkinson Disease (Early PD)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Early+Parkinson+Disease+%28Early+PD%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T23:27:40.363Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00332917", "title": "An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Early Stage Parkinson's Disease" ], "interventions": [ { "name": "Pardoprunox", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Solvay Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 224, "start_date": "2007-02", "completion_date": "2008-07", "has_results": false, "last_update_posted_date": "2009-01-26", "last_synced_at": "2026-06-10T23:27:40.363Z", "location_count": 25, "location_summary": "Huntsville, Alabama • Little Rock, Arkansas • Fountain Valley, California + 21 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00332917" }, { "nct_id": "NCT04201093", "title": "Fixed-Dose Trial in Early Parkinson's Disease (PD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "Tavapadon", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 529, "start_date": "2019-12-13", "completion_date": "2024-06-28", "has_results": true, "last_update_posted_date": "2025-07-28", "last_synced_at": "2026-06-10T23:27:40.363Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Fountain Valley, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04201093" }, { "nct_id": "NCT07267065", "title": "AAV2-hAADC for Parkinson's Disease (PDCS-01)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Parkinson's Disease (PD)", "Early Onset Parkinson Disease" ], "interventions": [ { "name": "AAV2-hAADC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Krzysztof Bankiewicz", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 9, "start_date": "2026-02-01", "completion_date": "2028-12-01", "has_results": false, "last_update_posted_date": "2025-12-05", "last_synced_at": "2026-06-10T23:27:40.363Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07267065" }, { "nct_id": "NCT00804479", "title": "The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "No intervention.", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 222, "start_date": "2002-01", "completion_date": "2004-03", "has_results": false, "last_update_posted_date": "2016-01-21", "last_synced_at": "2026-06-10T23:27:40.363Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00804479" }, { "nct_id": "NCT06757010", "title": "A Study of NE3107 in Early Parkinson's", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Parkinsons Disease (PD)" ], "interventions": [ { "name": "NE3107", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioVie Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "45 Years to 80 Years" }, "enrollment_count": 60, "start_date": "2025-03-26", "completion_date": "2026-05-31", "has_results": false, "last_update_posted_date": "2026-04-28", "last_synced_at": "2026-06-10T23:27:40.363Z", "location_count": 4, "location_summary": "Farmington Hills, Michigan • Amherst, New York • Morrisville, North Carolina + 1 more", "locations": [ { "city": "Farmington Hills", "state": "Michigan" }, { "city": "Amherst", "state": "New York" }, { "city": "Morrisville", "state": "North Carolina" }, { "city": "Canton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06757010" }, { "nct_id": "NCT00479401", "title": "Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Early Parkinson Disease (Early PD)" ], "interventions": [ { "name": "Pramipexol Extended Release", "type": "DRUG" }, { "name": "Pramipexol Immediate Release", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 539, "start_date": "2007-05", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-07-17", "last_synced_at": "2026-06-10T23:27:40.363Z", "location_count": 16, "location_summary": "Gilbert, Arizona • Sun City, Arizona • La Jolla, California + 13 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Oxnard", "state": "California" }, { "city": "Danbury", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00479401" }, { "nct_id": "NCT06966700", "title": "A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Neoplasms", "Triple Negative Breast Neoplasms", "HR Low-Positive/HER2-Negative Breast Neoplasms" ], "interventions": [ { "name": "Sacituzumab tirumotecan", "type": "BIOLOGICAL" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Rescue Medication", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Epirubicin", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Capecitabine", "type": "DRUG" }, { "name": "Olaparib", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2400, "start_date": "2025-06-30", "completion_date": "2034-12-29", "has_results": false, "last_update_posted_date": "2026-06-08", "last_synced_at": "2026-06-10T23:27:40.363Z", "location_count": 53, "location_summary": "Gilbert, Arizona • Phoenix, Arizona • Tucson, Arizona + 46 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Burbank", "state": "California" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06966700" }, { "nct_id": "NCT02642393", "title": "Study of Urate Elevation in Parkinson's Disease, Phase 3", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "Inosine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Michael Alan Schwarzschild", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 298, "start_date": "2016-06", "completion_date": "2019-06", "has_results": true, "last_update_posted_date": "2020-07-28", "last_synced_at": "2026-06-10T23:27:40.363Z", "location_count": 61, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 51 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02642393" }, { "nct_id": "NCT04288804", "title": "A Study to Analyze Symptoms Prevalent in Early PD (Dysphonia, Tremor)", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "Smartphone microphone sensor", "type": "DEVICE" }, { "name": "Smartphone accelerometer sensor", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Goalspal LLC", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1000, "start_date": "2020-02-26", "completion_date": "2023-12-26", "has_results": false, "last_update_posted_date": "2022-08-03", "last_synced_at": "2026-06-10T23:27:40.363Z", "location_count": 1, "location_summary": "Pleasanton, California", "locations": [ { "city": "Pleasanton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04288804" }, { "nct_id": "NCT00833690", "title": "Safety of Urate Elevation in Parkinson's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "inosine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Parkinson Study Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 75, "start_date": "2009-06", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2014-06-05", "last_synced_at": "2026-06-10T23:27:40.363Z", "location_count": 16, "location_summary": "Los Angeles, California • Manchester, Connecticut • New Haven, Connecticut + 12 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Manchester", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00833690" } ] }